VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim results from its ongoing comparative mouse study evaluating cell penetrating peptide (CPP) enabled, needle-free delivery of GLP/GIP-based therapies. In this interim analysis, animals treated with a novel semaglutide/CPP topical […]

“The AANA is extremely disappointed to see the U.S. Department of Education move forward with their proposal limiting federal graduate student loan borrowing available to Certified Registered Nurse Anesthetists (CRNAs) and other advanced practice nursing degrees. The real-world implication of this rule is devastating: A recent survey of AANA members showed 75% of CRNA-respondents reporting

(NASDAQ:NBRG), HONG KONG, CHINA, Jan. 29, 2026 (GLOBE NEWSWIRE) — Newbridge Acquisition Limited (NASDAQ: NBRG) (the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on the NASDAQ Capital Market (“NASDAQ”) and trade under the ticker symbol “NBRGU” beginning January

(NYSE:BRBR), NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds investors who purchased BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE:BRBR) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class

(NasdaqGM:MNOV),(TSE:4875.T),(TSE:4875), LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that as of the end of January 2026, 12 sites in the US are activated and 100 patients have

LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) — Mevolaxy has announced the next stage of development for its Mevstake direction – Mevstake 2.0. The key change in the new version lies in the product architecture: a format of personal MEV bots is being implemented instead of a shared operational model. In Mevstake 2.0, each participant

Newbridge Acquisition Limited Announces Pricing of $50 Million Initial Public Offering GlobeNewswire January 29, 2026 HONG KONG, CHINA, Jan. 29, 2026 (GLOBE NEWSWIRE) — Newbridge Acquisition Limited (NASDAQ: NBRG) (the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on

BRBR SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of BellRing Brands, Inc. Investors – Contact Kirby McInerney LLP by March 23, 2026 GlobeNewswire January 29, 2026 NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds investors who purchased BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE:BRBR) securities to contact Lauren Molinaro

Mevolaxy Announces The Next Stage of Development for Its Mevstake Direction: Mevstake 2.0 GlobeNewswire January 29, 2026 LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) — Mevolaxy has announced the next stage of development for its Mevstake direction – Mevstake 2.0. The key change in the new version lies in the product architecture: a format of

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MNâ€'166 (ibudilast) in ALS patients GlobeNewswire January 29, 2026 LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced